December 08, 2016 6:58 AM ET

Healthcare Equipment and Supplies

Company Overview of BioSig Technologies, Inc.

Company Overview

BioSig Technologies, Inc., a development stage medical device company, engages in developing a technology platform to minimize noise and artifacts from cardiac recordings during electrophysiology studies and ablation. Its products under development includes PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP system, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and ablation procedures. The company is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists i...

8441 Wayzata Boulevard

Suite 240

Minneapolis, MN 55426

United States

Founded in 2009

11 Employees

Phone:

763-999-7330

Key Executives for BioSig Technologies, Inc.

Chief Executive Officer, President and Director
Age: 59
Total Annual Compensation: $385.8K
Co-Founder and Executive Chairman
Age: 48
Total Annual Compensation: $368.1K
Chief Financial Officer
Age: 62
Total Annual Compensation: $102.5K
Compensation as of Fiscal Year 2015.

BioSig Technologies, Inc. Key Developments

BioSig Technologies, Inc. Approves Amendment its Amended and Restated Certificate of Incorporation

On November 18, 2016 at the special meeting of BioSig Technologies, Inc., the stockholders approved an amendment to the company's amended and restated certificate of incorporation to increase the number of authorized shares of common stock from 50,000,000 to 200,000,000 shares.

BioSig Technologies, Inc. Presents at LD Micro Main Event 2016, Dec-07-2016 11:30 AM

BioSig Technologies, Inc. Presents at LD Micro Main Event 2016, Dec-07-2016 11:30 AM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd, Los Angeles, CA 90049, United States. Speakers: Gregory D. Cash, Chief Executive Officer, President and Director.

BioSig Technologies, Inc. to Develop PURE EP™ System, a Novel Cardiac Electrophysiology Information System

BioSig Technologies, Inc. is developing the PURE EP™ System, a novel cardiac electrophysiology (EP) information system. The company's medical device product is on track to commercialization in 2017. The company's PURE EP™ System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system developed to assist electrophysiologists in making clinical decisions in real-time, albeit diagnostic or during an ablation procedure. Refined in collaboration with institutions such as the Texas Cardiac Arrhythmia Institute, Mayo Clinic, Mount Sinai and UCLA with data presented at world-renowned conferences, the PURE EP System has the potential to shorten procedure time and reduce the necessity for repeated procedures that are frequent with current devices. Recently, the PURE EP System was featured in an article written by researchers from the Mayo Clinic and published online in The Journal of the American College of Cardiology: Clinical Electrophysiology (JACCCEP). Many of EP systems have limited dynamic range, which translates into problems in needing to amplify small signals in order to see them, which ultimately distorts resolution and saturates large signals. Electrical noise is also an issue, which makes it difficult for clinicians to differentiate real physiologic signals from noise. BioSig's PURE EP System has shown effective in helping to solve these issues. Because the PURE EP qualifies with the FDA as a Class II medical device, extensive clinical trials are not required.  The company plans to file for a 510(k) marketing clearance which creates a relatively short path to commercialization, and only requires the company to show the device to be safe and substantially equivalent to another product on the market. The company intends to file its 510(k) application in the first half of 2017.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 28, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioSig Technologies, Inc., please visit www.biosigtech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.